Proof-of-concept study finds HIV-like virus particle could end need for need for lifelong medications

Development of the SIV Rev-dependent vectors to target SIV reservoirs. Credit: Gene Therapy (2024). DOI: 10.1038/s41434-024-00467-9

Researchers in George Mason University’s Center for Infectious…



Source link